Literature DB >> 8608356

Prognostic value of quantitative measurement of rheumatoid factor in early rheumatoid arthritis.

L Paimela1, T Palosuo, M Leirisalo-Repo, T Helve, K Aho.   

Abstract

The prognostic value of quantitative measurement of rheumatoid factor (RF) by immunoturbidimetry was evaluated in 78 patients with early rheumatoid arthritis (RA) during a 3-yr follow-up. After starting disease-modifying antirheumatic treatment, a significant improvement in conventional clinical and laboratory variables measuring disease activity was observed, while a steady increase was found in radiological progression. Initial RF levels correlated with radiologically determined joint damage up to 3 yr, whereas no correlation of other initially determined conventional variables of disease activity was found. High levels of RF at entry and persistent RF positivity during the follow-up were markers for destructive disease. Initial RF positivity alone was a sensitive predictor for later joint destruction, but quantitative measurement of the initial RF level and especially repeated measurements of RF seemed to add significantly to the prognostic value of RF in distinguishing between progressive and non-progressive disease in early RA.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8608356     DOI: 10.1093/rheumatology/34.12.1146

Source DB:  PubMed          Journal:  Br J Rheumatol        ISSN: 0263-7103


  6 in total

1.  High IgE in rheumatoid arthritis (RA) patients is complexed with anti-IgE autoantibodies.

Authors:  N Millauer; A W Zuercher; S M Miescher; H A Gerber; M Seitz; B M Stadler
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

2.  Association of autoantibodies to filaggrin with an active disease in early rheumatoid arthritis.

Authors:  L Paimela; T Palosuo; K Aho; M Lukka; P Kurki; M Leirisalo-Repo; R von Essen
Journal:  Ann Rheum Dis       Date:  2001-01       Impact factor: 19.103

3.  Levels of anti-citrullinated protein antibodies and IgM rheumatoid factor are not associated with outcome in early arthritis patients: a cohort study.

Authors:  Jennie Ursum; Wouter H Bos; Nancy van Dillen; Ben Ac Dijkmans; Dirkjan van Schaardenburg
Journal:  Arthritis Res Ther       Date:  2010-01-12       Impact factor: 5.156

4.  Does practice mirror the evidence base in the treatment of rheumatoid arthritis?

Authors:  Iain McInnes
Journal:  Clin Rheumatol       Date:  2009-05-13       Impact factor: 2.980

Review 5.  A scoping review of autoantibodies as biomarkers for canine autoimmune disease.

Authors:  Amy E Treeful; Emily L Coffey; Steven G Friedenberg
Journal:  J Vet Intern Med       Date:  2022-02-22       Impact factor: 3.333

Review 6.  Biomarkers in Rheumatoid Arthritis, what is new?

Authors:  B I Gavrilă; C Ciofu; V Stoica
Journal:  J Med Life       Date:  2016 Apr-Jun
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.